Tata Elxsi Limited (BOM:500408)
India flag India · Delayed Price · Currency is INR
3,622.05
-2.00 (-0.06%)
At close: Jul 9, 2026

Tata Elxsi Earnings Call Transcripts

Fiscal Year 2026

  • Q4 25/26

    Q4 FY26 saw modest revenue growth and margin improvement, led by transportation and media, while healthcare declined due to delayed deals. FY27 guidance is revised to high single-digit growth amid geopolitical and industry headwinds, with continued focus on AI, operational efficiency, and new verticals.

  • Q3 25/26

    Revenue grew 3.2% QoQ, led by a 7.7% rise in transportation, while EBITDA margin improved 220 bps to 23.3%. Media and healthcare are expected to recover from Q4, with utilization targeted to reach 80-85% before major hiring resumes.

  • Q2 25/26

    Q2 FY26 saw 2.9% revenue growth QoQ, with strong performance in transportation, media, and system integration, while healthcare declined slightly. H2 is expected to outperform H1, with margin recovery and double-digit growth targeted in automotive and healthcare.

  • Q1 25/26

    Q1 SY 2026 saw operating revenue of INR 892.1 crore and EBITDA margin of 20.9%, with transportation flat in constant currency and media and healthcare segments declining QoQ. Growth is expected to resume in transportation and media from Q2, with margin recovery targeted over the next three quarters.

Fiscal Year 2025

  • AGM 2025

    The AGM highlighted steady financial growth, a strong dividend, and strategic investments in AI, sustainability, and new verticals like aerospace and defense. Shareholders engaged actively on topics such as CapEx, ESG, and business diversification, with management addressing all queries and confirming ongoing focus on innovation and responsible growth.

  • Q4 24/25

    Q4 FY2025 saw revenue of INR 908.3 crores and a PBT margin of 23.3%, with large multi-year deals in automotive and media/communications providing a strong growth outlook. Management expects FY2026 to outperform FY2025, supported by improved utilization and cost discipline.

  • Q3 24/25

    Q3 saw steady revenues and modest growth across key verticals, with strong performance in India and Japan offsetting European weakness. Margins declined due to wage hikes and currency impacts, but management expects recovery and growth from large deal ramp-ups in coming quarters.

  • Q2 24/25

    Revenue grew 3.1% QoQ to INR 955.1 crores, led by transportation, while media and healthcare declined. EBITDA margin rose to 27.9%, and PAT increased 24.6% QoQ. Management targets double-digit growth for the year, supported by a strong deal pipeline.

  • Q1 24/25

    Q1 FY25 delivered steady revenue growth, led by transportation, while healthcare declined due to client delays. Margins were impacted by a one-time expense, but management maintains FY25 growth and margin guidance, with strong deal pipelines and continued investment in AI and digital.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021